Molecular Partners Ag Income Statement (2020-2025) | MOLN

Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 1.08M3.77M3.85M10.62M0.19M0.01M2.45M196.61M3.30M-1.95M0.00M0.00M0.00M0.00M0.79M4.91M-0.00M0.00M196.26
Operating items
Amortization - Deferred Charges 2.21-0.00M0.00M3.25-0.01M0.01M-3.24-0.01M0.01M-3.44-0.01M0.01M-4.45-0.01M0.01M
Research & Development 0.02M-34.65M-0.01M0.02M-28.09M-0.01M52.72M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M55.53M-0.01M-0.01M-0.01M
Selling, General & Administrative 0.00M-8.37M-0.01M0.01M-11.67M-0.01M23.10M-0.01M-0.01M-0.01M-0.01M-0.00M-0.01M20.09M-0.00M-0.00M-0.00M
Other Operating Expenses 19.04M-87.45M88.38M-85.77M-0.00M-143.76
Operating Expenses 0.02M-43.02M-0.02M19.04M0.02M-39.77M-0.02M-11.63M-0.02M-0.02M88.36M-0.02M-0.02M-0.02M-10.16M-0.02M-0.02M-0.02M
EBIT -0.02M-36.44M-0.01M0.17M154.65M-0.01M122.84M-0.02M-0.01M5.79M-0.01M-0.02M-0.02M-61.60M-0.02M-0.03M-0.01M
Non-operating items
Interest & Investment Income 0.00M1.69M717.74891.15-2.94M0.00M1.93M937.37-2.18M0.00M4.82M0.01M0.00M828.728.24M558.35507.31457.53
Net income details
EBT -0.02M-36.79M-0.01M0.17M154.14M-0.01M122.19M-0.02M-0.01M-0.02M-0.01M-0.02M-0.02M-61.64M-0.02M-0.02M-0.01M
Profit After Tax 171.97M-0.02M-36.79M-0.01M168.61M0.17M154.14M-0.02M-33.50M-0.02M-0.01M-28.04M-0.01M-0.02M-0.02M-61.64M-0.02M-0.03M-0.02M
Income from Continuing Operations -0.02M-36.79M-0.01M0.17M154.14M-0.01M122.19M-0.02M-0.01M-0.02M-0.01M-0.02M-0.02M-61.64M-0.02M-0.02M-0.01M
Consolidated Net Income -0.02M-36.79M-0.01M0.17M154.14M-0.01M122.19M-0.02M-0.01M-0.02M-0.01M-0.02M-0.02M-61.64M-0.02M-0.02M-0.01M
Income towards Parent Company -0.02M-36.79M-0.01M0.17M154.14M-0.01M122.19M-0.02M-0.01M-0.02M-0.01M-0.02M-0.02M-61.64M-0.02M-0.02M-0.01M
Net Income towards Common Stockholders -0.02M-36.79M-0.01M0.17M154.14M-0.01M122.19M-0.02M-0.01M-0.02M-0.01M-0.02M-0.02M-61.64M-0.02M-0.02M-0.01M
Additional items
EPS (Basic) 0.00-1.140.000.014.770.003.760.000.000.000.000.000.00-1.860.000.000.00
Shares Outstanding (Weighted Average) 32.16M32.16M32.16M32.16M32.16M32.33M32.33M32.50M32.51M32.54M32.83M32.84M32.85M32.87M33.18M33.19M36.86M36.87M37.39M
EBITDA -0.02M-36.44M-0.01M0.17M154.65M-0.01M122.84M-0.02M-0.01M5.79M-0.01M-0.02M-0.02M-61.60M-0.02M-0.03M-0.01M
Interest Expenses 195.770.35M-142.68269.620.51M-121.150.64M-602.211.95M-12.455.81M-11.46-19.90-0.00M0.04M0.00M-0.00M-196.26